More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia

Thursday, May 11, 2023

3:25 PM – 4:30 PM USA

Presenter(s)

Jonathan M. Meyer, MD

Voluntary Clinical Professor of Psychiatry
University of California, San Diego
University of California, San Diego
San Diego, California
Amber Hoberg, PMHNP-BC

Baptist Health Systems
Morning Star Family Medicine PLLC
San Antonio, Texas

Disclosure(s):

Jonathan M. Meyer, MD: No relevant disclosure to display

Amber Hoberg, PMHNP-BC: No relevant disclosure to display

Tardive dyskinesia (TD) continues to significantly diminish quality of life, impacting all aspects of patients’ lives and contributing to high rate of nonadherence to antipsychotic therapy and suboptimal outcomes. In this session, expert faculty will explain the impact on individuals with TD beyond the physical appearance, inform clinicians about assessment strategies for the detection and evaluation of TD, provide insight on the potential consequences among individuals with TD, and describe the practical differences between VMAT-2 inhibitors approved for TD in order to improve the management of TD and positively impact patient outcomes. Be sure to join our faculty in a live Q&A session immediately following their presentation where they will answer the most popular questions asked among clinicians. Supported by independent educational grants from Neurocrine Biosciences, Inc

Learning Objectives:

Assess the spectrum of potential consequences beyond physical appearance for individuals with TD, including negative impacts on physical, cognitive, and psychosocial functioning
Implement optimal assessment strategies for the detection and evaluation of TD
Evaluate the practical differences between novel VMAT-2 inhibitors approved for TD